Journal profile · GERIATRICS & GERONTOLOGY
Aging and Disease
ISSN 2152-5250 · International Society on Aging and Disease · UNITED STATES
Aging and Disease: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 9.3; fully open access; APC about USD 3,000; median 81 days to acceptance (109 articles, last 24 months); 236 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Aging and Disease is published by International Society on Aging and Disease and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroinflammation and Neurodegeneration Mechanisms, Alzheimer's disease research and treatments and Genetics, Aging, and Longevity in Model Organisms, together about 26% of its articles. Its main subfields are Physiology and Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Aging and Disease (A&D; Aging Dis) is a peer-reviewed, open-access journal dedicated to publishing novel and high-impact findings on key issues related to the biology of aging, the pathophysiology of age-related diseases, and innovative therapies targeting conditions that affect the aging population. Published by the International Society on Aging and Disease (ISOAD, www.isoad.org), the journal provides a multidisciplinary platform for researchers, clinicians, scholars, and public health professionals to share original and creative work exploring the intricate interplay between aging processes and age-related diseases. The journal publishes original research articles, short communications, reviews, perspectives, opinions, commentaries, and clinical studies on a wide range of aging and aging-related topics, including neurodegeneration (such as Alzheimer's disease), cardiovascular disease, metabolic syndromes (such as diabetes), cancer, osteoporosis, and immune dysfunction. Our mission is to advance scientific discovery and promote evidence-informed interventions—not only to extend lifespan, but to ensure healthier aging. Pubdate：2014-06-20 Viewed： 114497
From the journal's Aims & Scope
Research area (LetPub): GERIATRICS & GERONTOLOGY
Editor-in-chief Kunlin JinPublisher website
Editorial board by country: 3 in mainland China (about 9%); most named United States 20, Mainland China 3, Macau, China 2, United Kingdom 1, Japan 1 (35 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience11.9%
- Alzheimer's disease research and treatmentsMedicine8.3%
- Genetics, Aging, and Longevity in Model OrganismsBiochemistry, Genetics and Molecular Biology5.8%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology4.9%
- Telomeres, Telomerase, and SenescenceMedicine4.8%
- Neurological Disease Mechanisms and TreatmentsNeuroscience4.7%
- Diet and metabolism studiesMedicine4.4%
- Parkinson's Disease Mechanisms and TreatmentsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Geriatrics & Gerontology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 9.3LetPub ·
- Impact factor (publisher) 2025
- 9.6Publisher website ·
- CiteScore 2026-06
- 15.5LetPub ·
- SJR 2026-06
- 2.78LetPub ·
- SNIP 2026-06
- 1.91LetPub ·
- h-index
- 38LetPub ·
- h-index
- 107OpenAlex ·
- i10-index
- 1,061OpenAlex ·
- 2-year mean citedness
- 5.63OpenAlex ·
- Self-citation rate
- 4.2%LetPub ·
- Share of gold OA articles
- 98%LetPub ·
Volume
- Articles per year
- 317LetPub ·
Articles by year OpenAlex count · 1,770 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 148 | 148 | 49 |
| 2025 | 236 | 236 | 577 |
| 2024 | 254 | 254 | 2,964 |
| 2023 | 198 | 198 | 4,678 |
| 2022 | 202 | 202 | 7,024 |
| 2021 | 158 | 158 | 6,288 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
81 daysMedian, submission to acceptance · P25–P75 53 days – 106 days
- Acceptance to online
- median 8 days (111 articles)
- Submission to online
- median 97 days
- Sample
- 109 articles with submission and acceptance dates (450 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,000 | No | CC BY | |
| OpenAlex | USD 2,000 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 3,000 / USD 2,000 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- USD 3,000
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≤ 6
- Manuscript length
- ≤ 20,000 words
- Reference style
- Vancouver
- Templates
- Word
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted8
- commentaryA commentary offers an in-depth analysis or perspective on a previously published work.Length not stated
- correspondenceCorrespondence articles are concise reports that comment on, reanalyze, or expand upon previously published articles, or discuss timely issues of interest to th…Length not stated
- letters to the editorLetters to the Editor will be considered only if they pertain to articles recently published in Aging and Disease.Length not stated
- opinionAn opinion piece is a brief article expressing the author’s viewpoint or interpretation of a research study or scientific issue.Length not stated
- original articlesOriginal articles are peer reviewed and report details of original studies that have not been published previously.Length not stated
- perspectiveA perspective article presents the author's personal viewpoint on a specific topic.Length not stated
- reviewsReview articles provide a concise overview of a specific topic, typically within the author’s area of expertise.Length not stated
- short communicationShort Communications report findings of unusual urgency, significance, or novelty in the fields of biological aging and age-related diseases.Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Open access, Plagiarism
- License & copyright
CC BY licensing Model summary
A&D is Open Access is by licensing the content with a Creative Commons (CC) license (CC BY).
Source ↗Publisher website ·- Open access IV. Open Access statement
Open access under Creative Commons Attribution License Model summary
A&D is an open access journal, which means that all content is freely available without charge to the user or his/her institution under the terms of the Creative Commons Attribution License. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or …
Source ↗Publisher website ·- Plagiarism
Plagiarism screening using Turnitin and CrossCheck Model summary
To help editors verify the originality of submitted manuscripts, selected submitted manuscripts are scanned using the Plagiarism Prevention Software Turnitin and compared with the CrossCheck database.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- International Society on Aging and Disease
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2152-5250
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Aging and Disease
What CAS zone is Aging and Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Aging and Disease is in Zone 3 of Medicine, and in Zone 3 of the minor category Geriatrics & Gerontology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Aging and Disease?
The latest impact factor listed by LetPub is 9.3; CiteScore 15.5, h-index 107.
How long does peer review take at Aging and Disease?
Based on the dates recorded on 109 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 53–106 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Aging and Disease?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≤ 6; Manuscript length: ≤ 20,000 words; Reference style: Vancouver; Templates: Word; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Aging and Disease based?
Of the 35 board members whose country the journal's board page names, 3 (about 9%) are in mainland China; the countries named most often are United States (20), Mainland China (3) and Macau, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Aging and Disease?
According to LetPub and DOAJ records, Aging and Disease is indexed in SCIE, Scopus and DOAJ.
Is Aging and Disease open access, and what is the APC?
Aging and Disease is a fully open-access journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .